COVID-19: A Brief Overview of the Discovery Clinical Trial
Jean Jacques Vanden Eynde
Abstract
The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the European Discovery project.
Topics & Concepts
RepurposingCoronavirus disease 2019 (COVID-19)Clinical trialMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDrug repositioningOutbreakIntensive care medicineVirologyPharmacologyPathologyBiologyDrugInfectious disease (medical specialty)DiseaseEcologyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19